Beta Bionics CFO Stephen Feider sells 8,874 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Beta Bionics, Inc. (BBNX) Chief Financial Officer Stephen Feider exercised options covering 8,874 shares at an exercise price of $5.10 per share on November 11, 2026, acquired 8,874 common shares, and sold 8,874 shares at a weighted average of $17.2054 per share under a Rule 10b5-1 plan adopted July 31, 2026. Following the exercise, his option position was 29,695 shares. The options vest in 48 equal monthly installments measured from September 14, 2023.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) F3 | 8,874 | $0.00 | $0.00 |
| Exercise | Common Stock | 8,874 | $5.10 | $45K |
| Sale | Common Stock F1, F2 | 8,874 | $17.2054 | $153K |
Footnotes (3)
- F1. Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2026.
- F2. The weighted average sale price for the transaction reported was $17.2054 and the range of prices were between $17.00 and $17.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- F3. The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.
Key Figures
Key Terms
Rule 10b5-1 Plan regulatory
weighted average sale price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many BBNX options did Stephen Feider exercise, and what was the exercise price?
AI-generated analysis. How Rhea-AI works. Not financial advice.